BVMed
This article was originally published in The Gray Sheet
Executive Summary
Directive 98/79/EEC of the European Parliament and Council of October 27, 1998 on in vitro diagnostic medical devices, which went into effect on December 7, 1998, is required to be incorporated into member states' national legislation by December 7, 1999. This step will be accomplished in Germany by a "Second Amendment to the Medical Device Act," according to German device industry group BVMed's 1998 annual report, available on the Internet at http://www.bvmed.de/#English. By June 7, 2000, manufacturers marketing IVDs in Europe must be in a position to label their products with the CE mark. A transitional period allowing application of the Medical-Technical Equipment Ordinance in lieu of the CE mark will expire on Dec. 7, 2003
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.